Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.94 CHF | -0.24% | +0.38% | +9.54% |
08:07am | NOVARTIS AG : Berenberg remains Neutral | ZD |
06:01am | Novartis' Cosentyx Receives Canadian Approval for Hidradenitis Suppurativa Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.54% | 208B | |
+39.06% | 723B | |
+34.19% | 595B | |
-2.76% | 369B | |
+19.78% | 332B | |
+2.19% | 282B | |
+16.96% | 244B | |
-4.99% | 205B | |
+1.11% | 168B | |
+6.32% | 166B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis : Incyte 'Disappointed' After Planned COVID-19 Therapy Fails to Meet Target in Late-Stage Study